• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 27-Sep-2022 EOD, Market Closed
SENSEX
57,107.52
-37.70 (-0.07%)
NIFTY
17,007.40
-8.90 (-0.05%)
    No Companies Visited

EGM

Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date Remarks
EGM 16-Mar-2021 05-Feb-2021 NA NA COM 16/03/2021 Please find enclosed respective Notices of NCLT Convened Meeting of equity shareholders and unsecured creditors of the Company to be held on Tuesday, March 16, 2021 at 3.15 p.m. and 2.00 p.m. respectively. Submission of copies of Newspaper Advertisement regarding Notice of the National Company Law Tribunal ('NCLT') Convened Meetings of the Sun Pharmaceutical Industries Limited ('the Company') as per letter attached. (As Per BSE Announcement dated on 10.02.2021) As per letter attached (As Per BSE Announcement dated on 16.03.2021) Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 18.03.2021)
EGM 04-Jun-2019 30-Apr-2019 NA NA Notices of National Company Law Tribunal Convened Meetings of Equity Shareholders and Unsecured Creditors of Sun Pharmaceutical Industries Limited to be held on June 04, 2019 Submission of copies of Newspaper Advertisement regarding Notice of the National Company Law Tribunal ('NCLT') Convened Meetings of the Sun Pharmaceutical Industries Limited (As Per BSE Announcement Dated 13.05.2019) Proceedings of National Company Law Tribunal ("NCLT") convened separate meetings of the equity shareholders and unsecured creditors of Sun Pharmaceutical Industries Limited ("the Company") held today, June 04, 2019 (As Per BSE Announcement Dated on 04.06.2019) Ref: Clause 44(3) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we enclose herewith the details of the result of remote e-voting and electronic voting conducted at the NCLT convened meeting of equity shareholders of Sun Pharmaceutical Industries Limited held on June 04, 2019 at 10:15 a.m. 1ST at Prof. Chandravadan C. Mehta Auditorium - General Education Centre, Maharaja Sayajirao University of Baroda, Near D. N. Hall, Pratap Gunj, Vadodara-390 002, Gujarat, India for approval of the Composite Scheme of Arrangement among Sun Pharmaceutical Industries Limited and Sun Pharma (Netherlands) B.V., and Sun Pharmaceutical Holdings USA Inc., and their respective members and creditors ("Composite Scheme of Arrangement") along with the Scrutinizer''s Report. The said Composite Scheme of Arrangement was approved by the requisite majority of equity shareholders through remote e-voting and electronic voting conducted at the Meeting. We request you to kindly take note of the same. (As Per BSE Announcement Dated on 05.06.2019)
EGM 01-Jun-2018 17-Apr-2018 NA NA COM 01/06/2018 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of the Notices of the NCLT Convened Meetings dated April 04, 2018, for convening Meetings of the equity shareholders and unsecured creditors of the Company on Friday, June 01, 2018 at 10:15 a.m. IST and 11:15 a.m. IST respectively, as directed by Hon'ble NCLT, Ahmedabad Bench, vide its order dated February 21, 2018. Advertisement Published in Newspapers - Notice of Meeting of the Equity Shareholders and Unsecured Creditors of the Company convened as per the Directions of The National Company Law Tribunal, Ahmedabad Bench and for Notice of remote e-voting for NCLT Convened Meeting of equity shareholders of the Company. (As Per BSE Announcement Dated On 26/04/2018) Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated on 02.06.2018)
EGM 20-Jun-2017 19-May-2017 NA NA COM 20/06/2017 Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated on 22.06.2017) Pursuant to the order dated April 18, 2017, passed by the Hon'ble National Company Law Tribunal, Ahmedabad Bench, the separate meetings of equity shareholders and unsecured creditors of the Company were held at Sir Sayajirao Nagargruh, Akota, Vadodara- 390 020, Gujarat on Tuesday, June 20, 2017 at 10.15 a.m. and 11: 15 a.m. respectively, for approving the Scheme of Arrangement among Sun Pharma Medisales Private Limited, Ranbaxy Drugs Limited, Gufic Pharma Limited, Vidyut Investments Limited and the Company and their respective members and creditors. The resolution approving the Scheme of Arrangement was passed with requisite majority at the respective meetings of the equity shareholders and unsecured creditors. (As Per BSE Announcement Dated on 20.06.2017)
EGM 21-May-2017 12-May-2017 NA NA COM 21.05.2017
EGM 03-Jun-2015 04-May-2015 NA NA Sun Pharmaceuticals Industries Limited has submitted to the Exchange a copy of Notice of Court Convened Meeting of Shareholders of the Company to be held on June 03, 2015. Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of the Notice of Court Convened Meeting of the Shareholders of the Company to be held on June 03, 2015. (As Per BSE Announcement Dated on 08.05.2015) Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of the Court Convened Meeting of Equity Shareholders of the Company held on June 03, 2015, under Clause 35A. (As Per BSE Announcement Dated on 05.06.2015)
EGM 22-Aug-2014 31-Jul-2014 NA NA Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of the Notice of Court Convened Meeting of the shareholders of the Company to be held on August 22, 2014. Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results at the Court convened Meeting of Equity Shareholders of the Company held on August 22, 2014, under Clause 35A. (As Per BSE Announcement dated on 26/08/2014)
EGM 05-May-2014 21-Apr-2014 NA NA Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of the Notice of Court Convened Meeting of the shareholders of the Company to be held on May 05, 2014. Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results at the Court Convened Meeting of the Company held on May 05, 2014, under Clause 35A. (As Per BSE Announcement Dated on 09.05.2014)
EGM 25-Jan-2013 03-Jan-2013 NA NA Sun Pharmaceutical Industries Ltd has informed BSE that pursuant by an Order made on the December 21, 2012, the Hon'ble High Court of Gujarat, has directed that a Meeting of the Equity Shareholders of the Applicant Company be convened and held at the Prof. Chandravadan Mehta Auditorium, General Education Centre, Maharaja Sayajirao University of Baroda, Pratapgunj, Vadodara - 390 002, in the state of Gujarat on January 25, 2013 at 10.45 am. for the purpose of considering, and if thought fit, approving, with or without modification(s), the Scheme of Arrangement in the nature of Spin off and Transfer of the Domestic Formulation Undertaking of Sun Pharmaceutical Industries Limited, the Applicant Company into Sun Pharma Laboratories Limited, the Transferee Company, proposed to be made between Sun Pharmaceutical Industries Limited, Sun Pharma Laboratories Limited and their respective Shareholders. Sun Pharmaceutical Industries Ltd has informed BSE that the proceedings of Court Convened Meeting of Equity Shareholders of the Company held on January 25, 2013. (As per BSE Announcement Dated on 31.01.2013)
EGM 28-Jul-2007 06-Jul-2007 NA NA Sun Pharmaceutical Industries Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the members of the Company will be held on July 28, 2007, inter alia, to transact the following business: 1. To issue, offer and allot from time to time in one or more tranches and in consultation with the Lead Managers and/or Underwriters and/or other Advisors, Convertible Bonds, Debentures and / or Securities convertible into Equity Shares at the option of the Company or the holders thereof and / or securities with or without detachable warrants with or without right exercisable by the warrant holder to convert or subscribe to Equity Shares and / or Bonds or Foreign Currency Convertible Bonds or Securities through Global Depository Receipts, American Depository Receipts or any other Deposit Receipts or bonds or any other Securities or Financial Derivatives ("the Securities") to such Indian or Foreign Institutional Investors / Foreign Mutual Funds / Overseas Corporate Bodies / Foreigners / other Foreign parties/ Indian Financial Institutions / Companies / individuals / other persons or investors, whether or not they are members of the Company and / or by any one or more or a combination of the above modes / methods or otherwise by offering the Securities in the international market comprising one or more countries or domestic market or in any other approved manner through Prospectus and / or Offering Letter or Circular and / or on private placement basis as may be deemed appropriate by the Board such offer, issue and allotment to be made at such time or times at such issue price, face value, premium amount on issue / conversion of securities / exercise of warrants / redemption of Securities, rate of interest, redemption period, listing on one or more stock exchange in India and / or abroad and in such currency and in such manner and on such terms and conditions as the Board may think fit, for an aggregate amount (inclusive of such premium as may be fixed on the securities) not exceeding Rs 35,000 Million with power to the Board to settle details as to the form and terms of issue of the Securities, and all other terms, conditions and matters connected therewith or difficulties arising therefrom, subject to necessary provisions & approvals. 2. To borrow from time to time any sum or sums of monies which together with the monies already borrowed by the Company (apart from temporary loans obtained or to be obtained from the Company's bankers in the ordinary course of business) exceed the aggregate paid up capital of the Company and its free reserve, that is to say reserve not set apart for any specific purpose provided that the total amount so borrowed by the Board shall not at any time exceed the limit of Rs 50,000 Million, subject to necessary provisions & approvals. 3. To make loan(s) and/or give any guarantee(s)/provide any security(ies) in connection with loan(s) made to and to make investments in Shares, Debentures and / or any other Securities of other body corporates, whether Indian or overseas and / or in various schemes of Mutual Funds or such other funds, in their absolute discretion deem beneficial and in the interest of the Company in excess of 60% of the paid up Share Capital and Free Reserves of the Company or 100% of Free Reserves of the Company whichever is more, as prescribed under section 372A of the Companies Act, 1956 from time to time, in one or more tranches, upto maximum amount of Rs 50,000 Million notwithstanding that investments along with Company's existing loans or guarantee / security or investments shall be in excess of the limits prescribed under Section 372A aforesaid, subject to necessary provisions & approvals. Sun Pharmaceutical Industries Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on July 28, 2007, inter alia, have accorded to the following: 1. Authority to the Board to issue, offer and allot from time to time in one or more tranches, Convertible Bonds, Debentures and/or Securities convertible in to Equity Shares at the option of the Company or the holders thereof and/or securities with or without detachable warrants with or without right exercisable by the warrant holder to convert or subscribe to Equity Shares and/or Bonds or Foreign Currency Convertible Bonds or securities through Global Depository receipts, American Depository Receipts or any other Deposit Receipts or Bonds or any other Securities or Financial Derivatives in such currency, in such other manner and on such terms and conditions in accordance with the provisions of Section 81(1A) of the Companies Act, 1956 for an aggregate amount not exceeding Rs 35,000 Million. 2. Authority to the Board to borrow from time to time any sum or sums of monies which together with the monies already borrowed by the Company (apart from temporary loans obtained or to be obtained from the Company's bankers in the ordinary course of business) exceed the aggregate paid up capital of the Company and its free reserve as prescribed under Section 293(1)(d) of the Companies Act, 1956 and up to a maximum limit of Rs 50,000 Million. 3. Authority to the Board to make investments in shares, debentures and/or any other securities in excess of 60% of the paid-up share capital and free reserves of the Company or 100% of Free Reserves of the Company whichever is more, as prescribed under Section 372A of the Companies Act, 1956 and up to a maximum amount of Rs 50,000 Million. (As Per BSE Announcement Website Dated on 28/07/2007)
1 2 3 

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
9769005430
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 27-Sep-2022
  •  ( 15:50) Sensex, Nifty end flat after volatile session; oil & gas shares advance  
  •  ( 15:45) ICRA revises outlook on CMS Info Systems' rating to 'positive'  
  •  ( 15:40) Inox Wind commissions project in Gujarat  
  •  ( 14:36) Exide Inds commences work on lithium-ion cell manufacturing facility  
  •  ( 13:31) Nifty tad above 17,100; Sensex adds 332 pts; European stocks rise  
  •  ( 13:29) HFCL bags purchase orders worth Rs 202.60 crore  
  •  ( 13:09) GPT Infraprojects board OKs 1:1 bonus issue  
  •  ( 12:33) Oil & gas stocks advance  
  •  ( 12:32) Benchmarks trade with minor gains  
  •  ( 12:06) EKI Energy arm completes capacity expansion project in Maharashtra  
  •  ( 11:36) Indices trade almost flat, Metal stocks lose shine  
  •  ( 11:14) Optiemus Infracom arm partners with Dizo  
  •  ( 11:07) Shakti Pumps receives $6 mn advance for Uganda project  
  •  ( 10:48) Manappuram Finance board to mull debt issue in Oct'22  
  •  ( 10:36) Indices trim gains, Nifty below 17,050 mark, FMCG shares advance  
  •  ( 10:27) Orient Bell completes capex plan before schedule  
  •  ( 09:48) Jyoti Structures wins 237-cr order  
  •  ( 09:33) Market drifts higher in early trade; breadth strong  
  •  ( 09:27) STL divests stake in UK-based Impact Data Solutions  
  •  ( 09:23) Aarti Drugs reappoints Rashesh Gogri as MD for 5 years  
  •  ( 09:19) Mahindra Logistics acquires Rivigo's B2B express biz  
  •  ( 08:44) Asian stocks trading mixed  
  •  ( 08:25) U.S. stocks end mixed on global growth worries, rate fears  
Show News
27 September 2022 00:00
3470.40
(0.94 %)
737.30
(-0.69 %)
7240.90
(-0.20 %)
1679.65
(0.13 %)
760.60
(0.72 %)
4182.10
(1.20 %)
2290.15
(-0.83 %)
918.25
(1.25 %)
1414.35
(-0.76 %)
2678.95
(0.59 %)
852.85
(-0.96 %)
1164.40
(1.32 %)
1392.20
(0.90 %)
334.85
(0.69 %)
1801.25
(-1.52 %)
1840.10
(-0.60 %)
1235.75
(0.04 %)
8772.65
(-0.66 %)
18674.80
(1.19 %)
159.10
(0.35 %)
204.90
(1.81 %)
2395.40
(0.75 %)
536.25
(-1.39 %)
896.90
(-0.06 %)
97.60
(-2.25 %)
3018.65
(0.80 %)
1022.50
(-1.08 %)
2597.25
(-2.16 %)
6198.10
(0.35 %)
398.15
(0.86 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.